Nebraska Statutes 71-9603. Eligible patient
To be an eligible patient under the Investigational Drug Use Act, a person shall:
Terms Used In Nebraska Statutes 71-9603
- Person: shall include bodies politic and corporate, societies, communities, the public generally, individuals, partnerships, limited liability companies, joint-stock companies, and associations. See Nebraska Statutes 49-801
- Person shall: include bodies politic and corporate, societies, communities, the public generally, individuals, partnerships, limited liability companies, joint-stock companies, and associations. See Nebraska Statutes 49-801
- United States: shall include territories, outlying possessions, and the District of Columbia. See Nebraska Statutes 49-801
(1) Have an advanced illness, attested by the person‘s treating physician;
(2) Have considered all other treatment options approved by the United States Food and Drug Administration at the time;
(3) Have a recommendation from his or her treating physician for an investigational drug, biological product, or device;
(4) Give written, informed consent for the use of the investigational drug, biological product, or device;
(5) Have documentation from his or her treating physician that he or she meets the requirements of the act; and
(6) Not be a patient receiving inpatient treatment in a hospital licensed pursuant to the Health Care Facility Licensure Act.